Improved General and Height-Specific Quality of Life in Children With Short Stature After 1 Year on Growth Hormone
Author(s) -
Laura Gabriela González Briceño,
Magali Viaud,
Jacques Beltrand,
Isabelle Flechtner,
Yamina Dassa,
Dinane SamaraBoustani,
Caroline Thalassinos,
Christian Pauwels,
Kanetee Busiah,
Graziella Pinto,
D. Jaquet,
Michel Polak
Publication year - 2019
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-02523
Subject(s) - short stature , idiopathic short stature , growth hormone , pediatrics , hormone , medicine , endocrinology
Short stature in children and adolescents may lead to social and emotional stress, with negative effects on quality of life (QoL). GH treatment may improve QoL through height normalization. Our objective here was to evaluate general and height-specific QoL after 1 year of GH treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom